Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Jun 4;393(6684):480-3.
doi: 10.1038/31002.

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

S P Schoenberger  1 , R E Toes, E I van der Voort, R Offringa, C J Melief
Affiliations

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

S P Schoenberger et al. Nature. .

Abstract

Although in vivo priming of CD8+ cytotoxic T lymphocytes (CTLs) generally requires the participation of CD4+ T-helper lymphocytes, the nature of the 'help' provided to CTLs is unknown. One widely held view is that help for CTLs is mediated by cytokines produced by T-helper cells activated in proximity to the CTL precursor at the surface of an antigen-presenting cell (APC). An alternative theory is that, rather than being directly supplied to the CTL by the helper cell, help is delivered through activation of the APC, which can then prime the CTL directly. CD40 and its ligand, CD40L, may activate the APC to allow CTL priming. CD40L is expressed on the surface of activated CD4+ T-helper cells and is involved in their activation and in the development of their effector functions. Ligation of CD40 on the surface of APCs such as dendritic cells, macrophages and B cells greatly increases their antigen-presentation and co-stimulatory capacity. Here we report that signalling through CD40 can replace CD4+ T-helper cells in priming of helper-dependent CD8+ CTL responses. Blockade of CD40L inhibits CTL priming; this inhibition is overcome by signalling through CD40. CD40-CD40L interactions are therefore vital in the delivery of T-cell help for CTL priming.

PubMed Disclaimer

Comment in

  • Immunology. Licence to kill.
    Lanzavecchia A. Lanzavecchia A. Nature. 1998 Jun 4;393(6684):413-4. doi: 10.1038/30845. Nature. 1998. PMID: 9623994 No abstract available.

Similar articles

See all similar articles

Cited by

  • Selected anti-tumor vaccines merit a place in multimodal tumor therapies.
    Weiss EM, Wunderlich R, Ebel N, Rubner Y, Schlücker E, Meyer-Pittroff R, Ott OJ, Fietkau R, Gaipl US, Frey B. Weiss EM, et al. Front Oncol. 2012 Oct 9;2:132. doi: 10.3389/fonc.2012.00132. eCollection 2012. Front Oncol. 2012. PMID: 23087898 Free PMC article.
  • Consensus nomenclature for CD8+ T cell phenotypes in cancer.
    Apetoh L, Smyth MJ, Drake CG, Abastado JP, Apte RN, Ayyoub M, Blay JY, Bonneville M, Butterfield LH, Caignard A, Castelli C, Cavallo F, Celis E, Chen L, Colombo MP, Comin-Anduix B, Coukos G, Dhodapkar MV, Dranoff G, Frazer IH, Fridman WH, Gabrilovich DI, Gilboa E, Gnjatic S, Jäger D, Kalinski P, Kaufman HL, Kiessling R, Kirkwood J, Knuth A, Liblau R, Lotze MT, Lugli E, Marincola F, Melero I, Melief CJ, Mempel TR, Mittendorf EA, Odun K, Overwijk WW, Palucka AK, Parmiani G, Ribas A, Romero P, Schreiber RD, Schuler G, Srivastava PK, Tartour E, Valmori D, van der Burg SH, van der Bruggen P, van den Eynde BJ, Wang E, Zou W, Whiteside TL, Speiser DE, Pardoll DM, Restifo NP, Anderson AC. Apetoh L, et al. Oncoimmunology. 2015 Feb 25;4(4):e998538. doi: 10.1080/2162402X.2014.998538. eCollection 2015 Apr. Oncoimmunology. 2015. PMID: 26137416 Free PMC article.
  • Novel antibodies targeting immune regulatory checkpoints for cancer therapy.
    Lee CS, Cragg M, Glennie M, Johnson P. Lee CS, et al. Br J Clin Pharmacol. 2013 Aug;76(2):233-47. doi: 10.1111/bcp.12164. Br J Clin Pharmacol. 2013. PMID: 23701301 Free PMC article. Review.
  • Design of CD40 agonists and their use in growing B cells for cancer immunotherapy.
    Kornbluth RS, Stempniak M, Stone GW. Kornbluth RS, et al. Int Rev Immunol. 2012 Aug;31(4):279-88. doi: 10.3109/08830185.2012.703272. Int Rev Immunol. 2012. PMID: 22804572 Free PMC article. Review.
  • Decoding CAR T cell phenotype using combinatorial signaling motif libraries and machine learning.
    Daniels KG, Wang S, Simic MS, Bhargava HK, Capponi S, Tonai Y, Yu W, Bianco S, Lim WA. Daniels KG, et al. Science. 2022 Dec 16;378(6625):1194-1200. doi: 10.1126/science.abq0225. Epub 2022 Dec 8. Science. 2022. PMID: 36480602 Free PMC article.
See all "Cited by" articles

Publication types